{"id":"teriparatide-pf708","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Muscle weakness"}]},"_chembl":{"chemblId":"CHEMBL1201549","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by mimicking the natural parathyroid hormone, which helps to increase bone formation and decrease bone resorption, leading to an increase in bone mass and density.","oneSentence":"Teriparatide is a recombinant form of parathyroid hormone used to treat osteoporosis by stimulating bone growth.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:08.634Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of osteoporosis in postmenopausal women and men with a high risk of fractures"}]},"trialDetails":[{"nctId":"NCT07497503","phase":"PHASE1","title":"A Study of B-3E07 and Forsteo® in Healthy Adult Female Participants","status":"NOT_YET_RECRUITING","sponsor":"Syneos Health","startDate":"2026-04-10","conditions":"Healthy Volunteers","enrollment":48},{"nctId":"NCT05965167","phase":"PHASE1","title":"Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2023-05-11","conditions":"Hypoparathyroidism, Osteoporosis, Fractures, Bone","enrollment":45},{"nctId":"NCT05866029","phase":"NA","title":"Study of the Key Techniques of Prevention and Treatment of Osteoporotic Refracture","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-05-26","conditions":"Osteoporotic Fractures","enrollment":2478},{"nctId":"NCT01225055","phase":"PHASE2","title":"Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury","status":"COMPLETED","sponsor":"Thomas J. Schnitzer","startDate":"2010-10","conditions":"Spinal Cord Injury, Bone Loss, Osteoporosis","enrollment":60},{"nctId":"NCT03232476","phase":"PHASE4","title":"Effect of Mechanical Loading With PTH on Cortical Bone","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2017-07","conditions":"Osteoporosis, Postmenopausal","enrollment":""},{"nctId":"NCT07242612","phase":"NA","title":"Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Osteoporosis, Osteoporosis, Postmenopausal","enrollment":40},{"nctId":"NCT03735537","phase":"PHASE4","title":"Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2016-11-01","conditions":"Osteogenesis Imperfecta","enrollment":350},{"nctId":"NCT03994172","phase":"PHASE4","title":"Novel Combination Therapy for Osteoporosis in Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-07-01","conditions":"Male Osteoporosis","enrollment":40},{"nctId":"NCT04669782","phase":"NA","title":"Effect of Vitamin K Supplementation on Circulating Levels of Osteocalcin on the Bone Metabolism and Aging","status":"TERMINATED","sponsor":"University of Milano Bicocca","startDate":"2020-11-24","conditions":"Bone Metabolism Disorder, Aging Disorder, Osteoporosis","enrollment":99},{"nctId":"NCT06644040","phase":"PHASE1","title":"A Study of TeriQ Patch in Healthy Adult Female Participants","status":"COMPLETED","sponsor":"QuadMedicine","startDate":"2024-10-25","conditions":"Osteoporosis","enrollment":24},{"nctId":"NCT07028320","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2021-12-03","conditions":"Postmenopausal Women With Osteoporosis","enrollment":493},{"nctId":"NCT06951776","phase":"NA","title":"Chronotherapeutic Optimization of Teriparatide Administration in Postmenopausal Osteoporosis","status":"NOT_YET_RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2025-05-01","conditions":"Circadian Rhythm Disorders, Osteoporosis","enrollment":28},{"nctId":"NCT06164795","phase":"","title":"Sequential Therapies After Osteoanabolic Treatment","status":"RECRUITING","sponsor":"424 General Military Hospital","startDate":"2023-11-25","conditions":"Osteoporosis, Postmenopausal","enrollment":150},{"nctId":"NCT05151484","phase":"PHASE4","title":"Novel Precision Medicine Approach to Treatment of Osteoporosis Based on Bone Turnover","status":"RECRUITING","sponsor":"Madhumathi Rao","startDate":"2022-03-21","conditions":"Age-Related Osteoporosis","enrollment":60},{"nctId":"NCT06264609","phase":"PHASE4","title":"Precision Medicine Approach for Osteoporosis - Follow Up Study","status":"ENROLLING_BY_INVITATION","sponsor":"Paul F Netzel","startDate":"2024-02-01","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT06898060","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture","status":"NOT_YET_RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-06","conditions":"Postmenopausal Women With Osteoporosis","enrollment":282},{"nctId":"NCT06558188","phase":"PHASE4","title":"Combined Anabolic Therapy","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-02-03","conditions":"Osteoporosis, Postmenopausal, Osteoporosis","enrollment":50},{"nctId":"NCT06842758","phase":"","title":"Relationship Between Thoracic Hyperkyphosis and Fall Risk in Women with Fragility Vertebral Fractures","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Palermo","startDate":"2023-05-01","conditions":"Osteoporosis, Hyperkyphosis, Vertebral Body Fracture","enrollment":40},{"nctId":"NCT03133195","phase":"PHASE3","title":"The Effect of Teriparatide on Bone Union in Unstable Intertrochanteric Fracture Patients Treated With PFNA","status":"COMPLETED","sponsor":"King Chulalongkorn Memorial Hospital","startDate":"2017-05-17","conditions":"Unstable Intertrochanteric Fracture, Pertrochanteric Fracture of Femur, Closed","enrollment":50},{"nctId":"NCT03770338","phase":"NA","title":"Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2019-03-01","conditions":"Osteoporosis, Fusion of Spine, Lumbar Region","enrollment":192},{"nctId":"NCT01155245","phase":"","title":"Teriparatide (PTH) and Bone Strength in Postmenopausal Women","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2008-06","conditions":"Osteoporosis","enrollment":60},{"nctId":"NCT04522622","phase":"PHASE4","title":"Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease","status":"RECRUITING","sponsor":"Ditte Hansen","startDate":"2021-12-15","conditions":"Adynamic Bone Disease, Chronic Kidney Diseases, Cardiac Disease","enrollment":48},{"nctId":"NCT04974723","phase":"","title":"Real-world Effectiveness and Cardiovascular Safety Study of Abaloparatide in Postmenopausal Women","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2021-07-01","conditions":"Osteoporosis, Postmenopausal","enrollment":22054},{"nctId":"NCT02932501","phase":"","title":"Medication-related Osteonecrosis of the Jaw (MRONJ) Registry","status":"ACTIVE_NOT_RECRUITING","sponsor":"AO Clinical Investigation and Publishing Documentation","startDate":"2017-08-14","conditions":"Medication-related Osteonecrosis of the Jaw, Bisphosphonate-Associated Osteonecrosis of the Jaw","enrollment":518},{"nctId":"NCT06303284","phase":"PHASE1, PHASE2","title":"Post-surgical Outcomes With Anabolic Agent Use in High-risk Ankle Fractures: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"University of Calgary","startDate":"2025-01-01","conditions":"Ankle Fractures","enrollment":80},{"nctId":"NCT06061354","phase":"PHASE4","title":"Teriparatide on Maxillary Sinus Floor Osseointegration","status":"UNKNOWN","sponsor":"Universidad de Valparaiso","startDate":"2023-08-23","conditions":"Bone Regeneration","enrollment":42},{"nctId":"NCT04026256","phase":"PHASE4","title":"Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-09-02","conditions":"Postmenopausal Osteoporosis","enrollment":37},{"nctId":"NCT04879420","phase":"","title":"Replication of the VERO Osteoporosis Trial in Healthcare Claims Data","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2020-10-29","conditions":"Osteoporosis","enrollment":12757},{"nctId":"NCT01155232","phase":"","title":"Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2004-11","conditions":"Osteoporosis","enrollment":100},{"nctId":"NCT01896011","phase":"PHASE3","title":"Effect of Teriparatide on Fracture Healing in Patients With Incomplete Atypical Femur Fractures","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2013-07","conditions":"Non Displaced Atypical Femoral Fractures","enrollment":34},{"nctId":"NCT03072147","phase":"PHASE2","title":"Teriparatide as a Chondroregenerative Therapy in OA","status":"COMPLETED","sponsor":"Christopher Ritchlin","startDate":"2017-05-01","conditions":"Knee Osteoarthritis, Cartilage Degeneration","enrollment":76},{"nctId":"NCT02025179","phase":"PHASE2","title":"12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2013-01","conditions":"Spinal Cord Injury, Bone Loss, Osteoporosis","enrollment":25},{"nctId":"NCT05366621","phase":"","title":"Post-fracture Medication and Mortality","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-11-01","conditions":"Osteoporosis, Osteoporosis Fracture, Drug Therapy","enrollment":216155},{"nctId":"NCT02195895","phase":"PHASE2","title":"Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2014-04","conditions":"Spinal Cord Injury, Bone Loss, Osteoporosis","enrollment":17},{"nctId":"NCT04589819","phase":"PHASE4","title":"Fracture Recovery for Returning to Duty (Teriparatide STRONG)","status":"ENROLLING_BY_INVITATION","sponsor":"University of South Carolina","startDate":"2022-12-08","conditions":"Stress Fracture of Tibia or Fibula","enrollment":183},{"nctId":"NCT03472846","phase":"PHASE4","title":"MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2017-03-01","conditions":"Postmenopausal Osteoporosis, Diabetes Type 2","enrollment":26},{"nctId":"NCT02440581","phase":"NA","title":"Renal Osteodystrophy: An Individual Management Approach","status":"COMPLETED","sponsor":"Hartmut Malluche, MD","startDate":"2015-07-01","conditions":"Kidney Failure, Chronic","enrollment":141},{"nctId":"NCT02049866","phase":"PHASE2","title":"Denosumab for Prevention of Post-Teriparatide Bone Loss in Premenopausal Women With IOP","status":"COMPLETED","sponsor":"Elizabeth Shane","startDate":"2014-11-19","conditions":"Adult Idiopathic Generalized Osteoporosis","enrollment":33},{"nctId":"NCT01796301","phase":"PHASE3","title":"An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women","status":"COMPLETED","sponsor":"Amgen","startDate":"2013-01-31","conditions":"Postmenopausal Osteoporosis","enrollment":436},{"nctId":"NCT04750460","phase":"PHASE3","title":"Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).","status":"COMPLETED","sponsor":"Saint Petersburg State University, Russia","startDate":"2021-03-01","conditions":"Secondary Hyperparathyroidism, Chronic Kidney Disease-Mineral and Bone Disorder, Dialysis","enrollment":20},{"nctId":"NCT05164614","phase":"PHASE1","title":"Study Evaluating PK of PTH Administered Orally Via RaniPill™ Capsule","status":"COMPLETED","sponsor":"RANI Therapeutics","startDate":"2022-02-21","conditions":"Healthy Volunteers","enrollment":50},{"nctId":"NCT00896532","phase":"PHASE2","title":"Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-06-03","conditions":"Low Bone Mineral Density, Postmenopausal Osteoporosis","enrollment":419},{"nctId":"NCT02972424","phase":"PHASE2","title":"PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2017-05-01","conditions":"Osteoporotic Fractures","enrollment":35},{"nctId":"NCT05369013","phase":"","title":"Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile.","status":"UNKNOWN","sponsor":"STADA, Spain","startDate":"2021-06-15","conditions":"Osteoporosis","enrollment":188},{"nctId":"NCT00754442","phase":"NA","title":"Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2007-02","conditions":"Secondary Hyperparathyroidism","enrollment":20},{"nctId":"NCT02536898","phase":"NA","title":"Norwegian Capture the Fracture Initiative","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2015-05","conditions":"Hip Fracture, Vertebral Fracture, Other Low-trauma Fracture","enrollment":94260},{"nctId":"NCT03702140","phase":"PHASE2","title":"Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy","status":"UNKNOWN","sponsor":"Shinshu University","startDate":"2018-10-09","conditions":"Osteoporosis","enrollment":90},{"nctId":"NCT05018637","phase":"PHASE2","title":"Efficacy of WJ-derived Mesenchymal Stem Cells in Combination With Parathyroid Hormone for Vertebral Compression Fracture","status":"UNKNOWN","sponsor":"Inbo Han","startDate":"2020-09-01","conditions":"Vertebral Compression Fracture, Osteoporotic Fractures","enrollment":30},{"nctId":"NCT04921124","phase":"PHASE3","title":"Pharmacokinetic and PHarmacodynamic Analysis and Evaluation of Teriparatide (PTH 1-34) Between Sexes","status":"COMPLETED","sponsor":"Norfolk and Norwich University Hospitals NHS Foundation Trust","startDate":"2021-05-24","conditions":"Stress Fracture","enrollment":30},{"nctId":"NCT02023411","phase":"PHASE2","title":"Efficacy of Teriparatide in Diabetic Inactive Charcot Neuroarthropathy of Foot","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2014-01","conditions":"Diabetic Neuropathic Arthropathy","enrollment":20},{"nctId":"NCT02824718","phase":"PHASE2","title":"Recombinant Human rhPTH(1-34) VS Association Alfacalcidol/Hydrochlorothiazide in Severe Primary Hypoparathyroidism","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-06","conditions":"Autosomal Dominant Hypocalcemia OR Primary Hypoparathyroidism Related to Other Cause But Complicated by Hypercalciuria Under Treatment","enrollment":16},{"nctId":"NCT04003467","phase":"PHASE2","title":"A Six-month Phase 2 Study of Oral hPTH(1-34) (EBP05) in Postmenopausal Women With Low Bone Mass","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2019-06-30","conditions":"Osteoporosis","enrollment":161},{"nctId":"NCT01679080","phase":"PHASE2","title":"The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta","status":"TERMINATED","sponsor":"University of Aarhus","startDate":"2012-11","conditions":"Osteogenesis Imperfecta","enrollment":9},{"nctId":"NCT01292252","phase":"PHASE4","title":"Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion","status":"COMPLETED","sponsor":"Shane Burch","startDate":"2011-08","conditions":"Lumbar Spondylosis, Lumbar Spondylolisthesis, Adult Degenerative Lumbar Scoliosis","enrollment":36},{"nctId":"NCT04747392","phase":"PHASE1","title":"Bioequivalence Study of SAL001 and FORSTEO in Healthy Chinese Adults","status":"COMPLETED","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2020-08-19","conditions":"Postmenopausal Osteoporosis","enrollment":64},{"nctId":"NCT02176382","phase":"PHASE4","title":"Denosumab and Teriparatide Study (DATA-HD and DATA-EX)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2014-08","conditions":"Postmenopausal Osteoporosis","enrollment":76},{"nctId":"NCT04206618","phase":"","title":"Circulating Myokine Levels and Bone Metabolism","status":"COMPLETED","sponsor":"424 General Military Hospital","startDate":"2019-06-01","conditions":"Osteoporosis, Postmenopausal","enrollment":220},{"nctId":"NCT02252679","phase":"","title":"Study of the Diagnostic Value of Stable Calcium Isotope Profiling in Bone and Calcium Disorders","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-10","conditions":"Bone Diseases, Osteomalacia, Osteoporosis","enrollment":54},{"nctId":"NCT04196855","phase":"PHASE3","title":"Study of Teriparatide in Stress Fracture Healing","status":"UNKNOWN","sponsor":"University of East Anglia","startDate":"2019-12-23","conditions":"Stress Fracture, Parathyroid Hormone","enrollment":136},{"nctId":"NCT02156960","phase":"PHASE4","title":"Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients","status":"UNKNOWN","sponsor":"Shinshu University","startDate":"2014-05","conditions":"Osteoporosis","enrollment":100},{"nctId":"NCT02563353","phase":"NA","title":"PTH and Vibration in OSteoporosis Study","status":"COMPLETED","sponsor":"Odense University Hospital","startDate":"2015-11","conditions":"Osteoporosis","enrollment":35},{"nctId":"NCT01656629","phase":"NA","title":"Stem Cell Recruitment in Osteoporosis Therapy","status":"TERMINATED","sponsor":"Johns Hopkins University","startDate":"2012-08","conditions":"Low Bone Density","enrollment":55},{"nctId":"NCT04473989","phase":"PHASE2","title":"Weekly Use of Teriparatide to Accelerate Healing of Distal Radius Fracture","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-06-01","conditions":"Colles' Fracture","enrollment":80},{"nctId":"NCT04241211","phase":"PHASE4","title":"Comparative Study for Incidence of Proximal Junctional Kyphosis Between Parathyroid Hormone and Denosumab Following Adult Spinal Deformity Surgery : A Prospective, Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Seoul National University Bundang Hospital","startDate":"2014-01-01","conditions":"Spine Deformity","enrollment":64},{"nctId":"NCT01440803","phase":"PHASE2","title":"Forteo Trial on Idiopathic Osteoporosis in Premenopausal Women","status":"COMPLETED","sponsor":"Elizabeth Shane","startDate":"2012-08-02","conditions":"Adult Idiopathic Generalized Osteoporosis","enrollment":41},{"nctId":"NCT03217513","phase":"","title":"Knee Osteoarthritis Outcome Measures in Arthritic Patients With Osteoporosis","status":"WITHDRAWN","sponsor":"Edward Fox","startDate":"2020-01-01","conditions":"Osteoporosis, Knee Osteoarthritis","enrollment":""},{"nctId":"NCT04126941","phase":"","title":"Monocentric Study on the Use of Teriparatide in Children With hypoparathyroïdism","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2019-06-01","conditions":"Hypoparathyroidism","enrollment":9},{"nctId":"NCT00887354","phase":"PHASE4","title":"A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2009-04","conditions":"Osteoporosis","enrollment":224},{"nctId":"NCT01709110","phase":"PHASE4","title":"VERtebral Fracture Treatment Comparisons in Osteoporotic Women","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2012-10","conditions":"Postmenopausal Osteoporosis","enrollment":1366},{"nctId":"NCT00131469","phase":"PHASE4","title":"Study of Teriparatide (FORTEO) to Treat Adults With Osteogenesis Imperfecta","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2005-06","conditions":"Osteogenesis Imperfecta","enrollment":79},{"nctId":"NCT02090244","phase":"PHASE4","title":"Does PTH 1-34 (Teriparatide) Enhance Spinal Fusion in Humans?","status":"COMPLETED","sponsor":"University Hospital, Linkoeping","startDate":"2012-08","conditions":"Spinal Stenosis","enrollment":34},{"nctId":"NCT02239523","phase":"NA","title":"Effectiveness or Orthopedic Intervention in Osteoporosis Management After a Fracture of the Hip With Cost-Benefit Analysis","status":"COMPLETED","sponsor":"Shaare Zedek Medical Center","startDate":"2017-02-21","conditions":"Osteoporotic Fracture","enrollment":200},{"nctId":"NCT02472782","phase":"","title":"Adherence to Osteoporosis Treatment and Physicians' Perception Regarding Osteoporosis Medication","status":"COMPLETED","sponsor":"251 Hellenic Air Force & VA General Hospital","startDate":"2015-05","conditions":"Osteoporosis, Postmenopausal, Osteoporosis, Steroid Induced","enrollment":851},{"nctId":"NCT03720886","phase":"PHASE1, PHASE2","title":"G56W1 in Women With Postmenopausal Osteoporosis","status":"UNKNOWN","sponsor":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","startDate":"2018-10-01","conditions":"Postmenopausal Osteoporosis","enrollment":148},{"nctId":"NCT03692143","phase":"","title":"Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2017-01-01","conditions":"Osteoporosis, Postmenopausal, Vertebral Fracture, Quality of Life","enrollment":90},{"nctId":"NCT00489918","phase":"PHASE2","title":"Dose Ranging Study - Macroflux Parathyroid Hormone (PTH) in Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Zosano Pharma Corporation","startDate":"2007-06","conditions":"Osteoporosis","enrollment":165},{"nctId":"NCT00697463","phase":"PHASE2, PHASE3","title":"Forteo for the Treatment of Unexplained Osteoporosis in Premenopausal Women","status":"COMPLETED","sponsor":"Columbia University","startDate":"2008-08-20","conditions":"Menopause, Fracture, Osteoporosis","enrollment":22},{"nctId":"NCT00926380","phase":"PHASE2","title":"Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2009-06","conditions":"Osteoporosis","enrollment":94},{"nctId":"NCT03002428","phase":"PHASE3","title":"A Comparison of PF708 and Forteo in Osteoporosis Patients","status":"COMPLETED","sponsor":"Pfenex, Inc","startDate":"2016-12","conditions":"Osteoporosis","enrollment":181},{"nctId":"NCT02637180","phase":"","title":"Secondary Prevention of Osteoporotic Fractures: a Multiple Center Fracture Liaison Service in Greece","status":"COMPLETED","sponsor":"Hellenic Society for the Study of Bone Metabolism","startDate":"2015-04","conditions":"Osteoporosis","enrollment":397},{"nctId":"NCT01279187","phase":"PHASE2","title":"The Impact of Parathyroid Hormone (PTH) on Craniofacial Osseous Regeneration in Bone","status":"TERMINATED","sponsor":"University of Michigan","startDate":"2011-02","conditions":"Implant","enrollment":27},{"nctId":"NCT02571140","phase":"PHASE1","title":"A Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Oral PTH (1-34) Formulations in Healthy Subjects","status":"COMPLETED","sponsor":"Entera Bio Ltd.","startDate":"2013-10","conditions":"Drug Safety and Bioavailability","enrollment":30},{"nctId":"NCT01705587","phase":"PHASE4","title":"Fracture (FX) Improvement With Teriparatide: FiX-IT Study","status":"COMPLETED","sponsor":"Susan L. Greenspan","startDate":"2012-12","conditions":"Osteoporosis, Atypical Femoral Fracture","enrollment":13},{"nctId":"NCT00471237","phase":"PHASE2","title":"A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2007-05-14","conditions":"Osteoporosis","enrollment":564},{"nctId":"NCT00542425","phase":"PHASE2","title":"Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2007-04","conditions":"Osteoporosis","enrollment":222},{"nctId":"NCT02130973","phase":"PHASE4","title":"The Treatment of Osteoporosis Using a Combination of Teriparatide (Forteo) and Denosumab","status":"UNKNOWN","sponsor":"Health Research, Inc.","startDate":"2013-08","conditions":"Osteoporosis","enrollment":60},{"nctId":"NCT00668941","phase":"PHASE2","title":"Cyclic Versus Daily Teriparatide on Bone Mass","status":"UNKNOWN","sponsor":"Helen Hayes Hospital","startDate":"2005-09","conditions":"Osteoporosis","enrollment":140},{"nctId":"NCT01153425","phase":"PHASE4","title":"µMRI of Therapeutic Intervention in Postmenopausal Osteoporosis","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2008-07","conditions":"Osteoporosis, Osteopenia","enrollment":33},{"nctId":"NCT00759772","phase":"PHASE2","title":"The Role of Parathyroid Hormone (PTH) in Low Bone Mass in Anorexia Nervosa","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-09","conditions":"Anorexia Nervosa, Osteoporosis","enrollment":23},{"nctId":"NCT01293292","phase":"PHASE4","title":"Teriparatide (Forsteo) Treatment in Postmenopausal Women: Mechanism of Action","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2011-01","conditions":"Osteoporosis","enrollment":19},{"nctId":"NCT00361595","phase":"NA","title":"Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2006-08","conditions":"Osteoporosis","enrollment":35},{"nctId":"NCT01400516","phase":"PHASE4","title":"Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2011-08","conditions":"Rheumatoid Arthritis","enrollment":26},{"nctId":"NCT01750086","phase":"PHASE4","title":"Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2013-01","conditions":"Postmenopausal Osteoporosis","enrollment":27},{"nctId":"NCT01343004","phase":"PHASE3","title":"Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women","status":"COMPLETED","sponsor":"Radius Health, Inc.","startDate":"2011-04","conditions":"Osteoporosis, Postmenopausal Osteoporosis","enrollment":2463},{"nctId":"NCT01935479","phase":"PHASE1","title":"A Phase I Study of AK159 in Healthy Postmenopausal Women","status":"COMPLETED","sponsor":"Asahi Kasei Pharma Corporation","startDate":"2013-08","conditions":"Osteoporosis","enrollment":170},{"nctId":"NCT02304887","phase":"","title":"The Relationship Between the Residual Renal Function and Osteoporosis Treatment","status":"UNKNOWN","sponsor":"Toshihiko Kono","startDate":"2006-01","conditions":"Osteoporosis","enrollment":1000},{"nctId":"NCT01309399","phase":"NA","title":"Early Effects of Parathyroid Hormone (PTH) on the Proximal Femur","status":"COMPLETED","sponsor":"Health Research, Inc.","startDate":"2010-08","conditions":"Osteoporosis","enrollment":40},{"nctId":"NCT02955056","phase":"PHASE4","title":"Ankle Fractures Treated With Teriparatide","status":"UNKNOWN","sponsor":"Nottingham University Hospitals NHS Trust","startDate":"2016-10","conditions":"Fracture, Ankle","enrollment":10},{"nctId":"NCT02166437","phase":"","title":"Clinical Results of Bisphosphonate and Denosumab Therapy Following Teriparatide Therapy for Japanese","status":"UNKNOWN","sponsor":"Tomidahama Hospital","startDate":"2013-11","conditions":"Osteoporosis","enrollment":500},{"nctId":"NCT01956461","phase":"","title":"Effects of Teriparatide Therapy for Japanese","status":"UNKNOWN","sponsor":"Tomidahama Hospital","startDate":"2010-09","conditions":"Osteoporosis","enrollment":500}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Teriparatide (PF708)","genericName":"Teriparatide (PF708)","companyName":"Pfenex, Inc","companyId":"pfenex-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Teriparatide is a recombinant form of parathyroid hormone used to treat osteoporosis by stimulating bone growth. Used for Treatment of osteoporosis in postmenopausal women and men with a high risk of fractures.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}